Erratum

“Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial” by Carmen J. Allegra, Greg Yothers, Michael J. O’Connell, Robert W. Beart,Timothy F. Wozniak, Henry C. Pitot, Anthony F. Shields, Jerome C. Landry, David P. Ryan, Amit Arora, Lisa S. Evans, Nathan Bahary, Gamini Soori, Janice F. Eakle, John M. Robertson, Dennis F. Moore Jr, Michael R. Mullane, Benjamin T. Marchello, Patrick J. Ward, Saima Sharif, Mark S. Roh, Norman Wolmark. J Natl Cancer Inst 2015; 107(11): djv248 doi: 10.1093/jnci/djv248 . The hazard ratio value in Figure 5B should have been 0.89 instead of 0.94. The authors regret the error.